KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Q3 2025 value amounting to $6.4 billion.

  • Jazz Pharmaceuticals' Goodwill & Intangibles fell 799.62% to $6.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 billion, marking a year-over-year decrease of 799.62%. This contributed to the annual value of $6.5 billion for FY2024, which is 974.95% down from last year.
  • According to the latest figures from Q3 2025, Jazz Pharmaceuticals' Goodwill & Intangibles is $6.4 billion, which was down 799.62% from $6.6 billion recorded in Q2 2025.
  • Jazz Pharmaceuticals' Goodwill & Intangibles' 5-year high stood at $9.5 billion during Q2 2021, with a 5-year trough of $3.0 billion in Q1 2021.
  • Moreover, its 5-year median value for Goodwill & Intangibles was $7.2 billion (2022), whereas its average is $7.2 billion.
  • In the last 5 years, Jazz Pharmaceuticals' Goodwill & Intangibles skyrocketed by 19573.32% in 2021 and then tumbled by 2156.23% in 2022.
  • Over the past 5 years, Jazz Pharmaceuticals' Goodwill & Intangibles (Quarter) stood at $9.0 billion in 2021, then fell by 16.62% to $7.5 billion in 2022, then fell by 4.22% to $7.2 billion in 2023, then fell by 9.75% to $6.5 billion in 2024, then fell by 1.22% to $6.4 billion in 2025.
  • Its last three reported values are $6.4 billion in Q3 2025, $6.6 billion for Q2 2025, and $6.5 billion during Q1 2025.